GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum

Ken ichi Tanaka, Michiyo Yoshioka, Ikuko Miyazaki, Naoko Fujita, Norio Ogawa

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

We investigated both the antioxidant activities of GPI1046, a non-immunosuppressive derivative of FK506, and the in vivo neuroprotective properties against toxicity of intracerebroventricular 6-hydroxydopamine (6-OHDA) in mice. The 6-OHDA-induced reduction in dopamine and its metabolites in the striatum was significantly normalized by daily administration of GPI1046. Moreover, GPI1046 significantly reduced lipid peroxidation in vivo. Further, GPI1046 significantly increased striatal glutathione (GSH) levels by activating GSH synthesis, although the striatal catalase and superoxide dismutase activities did not change. We conclude that GPI1046 may have neuroprotective effects both in cell cultures and in vivo.

Original languageEnglish
Pages (from-to)45-48
Number of pages4
JournalNeuroscience Letters
Volume321
Issue number1-2
DOIs
Publication statusPublished - Mar 15 2002

Fingerprint

Oxidopamine
Glutathione
Corpus Striatum
Tacrolimus
Neuroprotective Agents
Catalase
Lipid Peroxidation
Superoxide Dismutase
Dopamine
Cell Culture Techniques
Antioxidants

Keywords

  • 6-Hydroxydopamine
  • Antioxidant
  • FK506 binding protein
  • Neuroimmunophilin
  • Non-immunosuppressive immunophilin ligands
  • Tacrolimus

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum. / Tanaka, Ken ichi; Yoshioka, Michiyo; Miyazaki, Ikuko; Fujita, Naoko; Ogawa, Norio.

In: Neuroscience Letters, Vol. 321, No. 1-2, 15.03.2002, p. 45-48.

Research output: Contribution to journalArticle

Tanaka, Ken ichi ; Yoshioka, Michiyo ; Miyazaki, Ikuko ; Fujita, Naoko ; Ogawa, Norio. / GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum. In: Neuroscience Letters. 2002 ; Vol. 321, No. 1-2. pp. 45-48.
@article{c6ec8f418b2042d0b3c3d1b785a448af,
title = "GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum",
abstract = "We investigated both the antioxidant activities of GPI1046, a non-immunosuppressive derivative of FK506, and the in vivo neuroprotective properties against toxicity of intracerebroventricular 6-hydroxydopamine (6-OHDA) in mice. The 6-OHDA-induced reduction in dopamine and its metabolites in the striatum was significantly normalized by daily administration of GPI1046. Moreover, GPI1046 significantly reduced lipid peroxidation in vivo. Further, GPI1046 significantly increased striatal glutathione (GSH) levels by activating GSH synthesis, although the striatal catalase and superoxide dismutase activities did not change. We conclude that GPI1046 may have neuroprotective effects both in cell cultures and in vivo.",
keywords = "6-Hydroxydopamine, Antioxidant, FK506 binding protein, Neuroimmunophilin, Non-immunosuppressive immunophilin ligands, Tacrolimus",
author = "Tanaka, {Ken ichi} and Michiyo Yoshioka and Ikuko Miyazaki and Naoko Fujita and Norio Ogawa",
year = "2002",
month = "3",
day = "15",
doi = "10.1016/S0304-3940(01)02547-2",
language = "English",
volume = "321",
pages = "45--48",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - GPI1046 prevents dopaminergic dysfunction by activating glutathione system in the mouse striatum

AU - Tanaka, Ken ichi

AU - Yoshioka, Michiyo

AU - Miyazaki, Ikuko

AU - Fujita, Naoko

AU - Ogawa, Norio

PY - 2002/3/15

Y1 - 2002/3/15

N2 - We investigated both the antioxidant activities of GPI1046, a non-immunosuppressive derivative of FK506, and the in vivo neuroprotective properties against toxicity of intracerebroventricular 6-hydroxydopamine (6-OHDA) in mice. The 6-OHDA-induced reduction in dopamine and its metabolites in the striatum was significantly normalized by daily administration of GPI1046. Moreover, GPI1046 significantly reduced lipid peroxidation in vivo. Further, GPI1046 significantly increased striatal glutathione (GSH) levels by activating GSH synthesis, although the striatal catalase and superoxide dismutase activities did not change. We conclude that GPI1046 may have neuroprotective effects both in cell cultures and in vivo.

AB - We investigated both the antioxidant activities of GPI1046, a non-immunosuppressive derivative of FK506, and the in vivo neuroprotective properties against toxicity of intracerebroventricular 6-hydroxydopamine (6-OHDA) in mice. The 6-OHDA-induced reduction in dopamine and its metabolites in the striatum was significantly normalized by daily administration of GPI1046. Moreover, GPI1046 significantly reduced lipid peroxidation in vivo. Further, GPI1046 significantly increased striatal glutathione (GSH) levels by activating GSH synthesis, although the striatal catalase and superoxide dismutase activities did not change. We conclude that GPI1046 may have neuroprotective effects both in cell cultures and in vivo.

KW - 6-Hydroxydopamine

KW - Antioxidant

KW - FK506 binding protein

KW - Neuroimmunophilin

KW - Non-immunosuppressive immunophilin ligands

KW - Tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=0037087049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037087049&partnerID=8YFLogxK

U2 - 10.1016/S0304-3940(01)02547-2

DO - 10.1016/S0304-3940(01)02547-2

M3 - Article

C2 - 11872253

AN - SCOPUS:0037087049

VL - 321

SP - 45

EP - 48

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1-2

ER -